Evidence map›Paper›PMID 35017512›Full record

ArticleNature communications2022

Structural insights in cell-type specific evolution of intra-host diversity by SARS-CoV-2.

Kapil Gupta, Christine Toelzer, Maia Kavanagh Williamson, Deborah K Shoemark, A Sofia F Oliveira, David A Matthews, Abdulaziz Almuqrin, Oskar Staufer, Sathish K N Yadav, Ufuk Borucu and 7 more

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Viruses · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Graphene sandwich-based biological specimen preparation for cryo-EM analysis.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Antibody therapeutics · 2023
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Kapil Gupta *School of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol, BS8 1TD, UK. kapil.gupta@bristol.ac.uk.ORCID 0000-0002-2115-3503
Christine Toelzer *School of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol, BS8 1TD, UK.ORCID 0000-0001-9984-5940
Maia Kavanagh Williamson *School of Cellular and Molecular Medicine, University of Bristol, University Walk, Bristol, BS8 1TD, UK.
Deborah K Shoemark *School of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol, BS8 1TD, UK.ORCID 0000-0002-1240-8463
A Sofia F OliveiraSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol, BS8 1TD, UK.ORCID 0000-0001-8753-4950
David A MatthewsSchool of Cellular and Molecular Medicine, University of Bristol, University Walk, Bristol, BS8 1TD, UK.ORCID 0000-0003-4611-8795
Abdulaziz AlmuqrinSchool of Cellular and Molecular Medicine, University of Bristol, University Walk, Bristol, BS8 1TD, UK.
Oskar StauferDepartment for Cellular Biophysics, Max Planck Institute for Medical Research, Jahnstraße 29, 69120, Heidelberg, Germany.ORCID 0000-0002-8015-3132
Sathish K N YadavSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol, BS8 1TD, UK.
Ufuk BorucuSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol, BS8 1TD, UK.
Frederic GarzoniImophoron Ltd, St. Philips Central, Albert Rd, St. Philips, Bristol, BS2 0XJ, UK.
Daniel FitzgeraldHalo Therapeutics Ltd, St. Philips Central, Albert Rd, St. Philips, Bristol, BS2 0XJ, UK.
Joachim SpatzDepartment for Cellular Biophysics, Max Planck Institute for Medical Research, Jahnstraße 29, 69120, Heidelberg, Germany.ORCID 0000-0003-3419-9807
Adrian J MulhollandSchool of Chemistry, University of Bristol, Cantock's Close, Bristol, BS8 1TS, UK.ORCID 0000-0003-1015-4567
Andrew D DavidsonSchool of Cellular and Molecular Medicine, University of Bristol, University Walk, Bristol, BS8 1TD, UK.
Christiane SchaffitzelSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol, BS8 1TD, UK. cb14941@bristol.ac.uk.ORCID 0000-0002-1516-9760
Imre BergerSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol, BS8 1TD, UK. imre.berger@bristol.ac.uk.ORCID 0000-0001-7518-9045

Funding

FDA HHS HHSF223201510104CMedical Research Council MR/R020566/1Medical Research Council MR/V027506/1RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/L01386X/1RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/P000940/1RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/R013764/1RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/R511663/1Wellcome TrustWellcome Trust (Wellcome) 106115/Z/14/Z
6 · The paper itself

Abstract

As the global burden of SARS-CoV-2 infections escalates, so does the evolution of viral variants with increased transmissibility and pathology. In addition to this entrenched diversity, RNA viruses can also display genetic diversity within single infected hosts with co-existing viral variants evolving differently in distinct cell types. The BriSΔ variant, originally identified as a viral subpopulation from SARS-CoV-2 isolate hCoV-19/England/02/2020, comprises in the spike an eight amino-acid deletion encompassing a furin recognition motif and S1/S2 cleavage site. We elucidate the structure, function and molecular dynamics of this spike providing mechanistic insight into how the deletion correlates to viral cell tropism, ACE2 receptor binding and infectivity of this SARS-CoV-2 variant. Our results reveal long-range allosteric communication between functional domains that differ in the wild-type and the deletion variant and support a view of SARS-CoV-2 probing multiple evolutionary trajectories in distinct cell types within the same infected host.

Indexed as

AnimalsCell LineCOVID-19Cryoelectron MicroscopyEvolution, MolecularFurinHumansLinoleic AcidMolecular Dynamics SimulationMutationProtein BindingProtein ConformationSARS-CoV-2Spike Glycoprotein, CoronavirusViral TropismVirus InternalizationFurinLinoleic AcidSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID35017512
PMCPMC8752678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.